HeartSciences (HSCSW) Operating Expenses (2021 - 2026)

HeartSciences has reported Operating Expenses for 6 years, with the latest figure at $1.9 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses fell 18.66% year-over-year to $1.9 million; the trailing twelve-month figure through Jan 2026 stood at $7.8 million (down 6.14% YoY), and the FY2025 full-year result was $8.4 million, up 32.24% from the prior year.
• Operating Expenses for Q1 2026 stood at $1.9 million, down from $2.1 million in the prior quarter.
• The five-year high for Operating Expenses was $2.4 million in Q1 2025, with the low at $1.1 million in Q1 2022.
• Historically, Operating Expenses has averaged $1.8 million across 5 years, with a median of $1.9 million in 2025.
• Annual changes were most pronounced in 2022 — Operating Expenses surged 111.67% — and 2023, when it decreased 19.29%.
• HeartSciences' Operating Expenses stood at $1.8 million in 2022, then slipped by 11.41% to $1.6 million in 2023, then rose by 26.25% to $2.0 million in 2024, then gained by 4.52% to $2.1 million in 2025, then decreased by 7.03% to $1.9 million in 2026.
• The last three Operating Expenses figures came in at $1.9 million (Q1 2026), $2.1 million (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.